Drug intelligence / Profile preview

allogeneic umbilical cord-derived mesenchymal stromal cells

Development stage: Unknown
Lead developer: Duke University
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intraarticular

Overview

Allogeneic umbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a cell-based biologic therapy utilizing mesenchymal stromal cells harvested from donor umbilical cord tissue, specifically Wharton's jelly. These cells possess potent immunomodulatory, proangiogenic, and antifibrotic properties, making them candidates for treating a variety of immune-mediated and inflammatory diseases. Their primary mechanism involves the modulation of regulatory T cells (Tregs) and the suppression of pro-inflammatory T-lymphocytes and inflammatory pathways. UC-MSCs are currently being investigated in clinical trials for conditions such as autism spectrum disorder, cerebral palsy, systemic lupus erythematosus, and Crohn's disease-related perianal fistulas.

Other names: UC-MSCshuman umbilical cord tissue-derived mesenchymal stromal cellswharton's jelly mesenchymal stromal cells

Beyond the preview

Go deeper on allogeneic umbilical cord-derived mesenchymal stromal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic umbilical cord-derived mesenchymal stromal cells.

Explore the full profile